Partoza, Juliemar L.

HRN: 06-38-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
CEFTRIAXONE 1G (VIAL)
05/04/2026
05/11/2026
IV
2g
Q24
Multiple Abrasion Sec To RCI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: